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ABSTRACT
The fi eld of bionanotechnology has been rapidly growing during the last few years and we can now envision 
a controllable integration between biological and artificial matter, where new biomimetic structures with a 
wide range of chemical and physical properties will promote the development of a novel generation of medical 
devices. In this work we describe a collagen/carbon nanotube composite which has the potential to be used 
as a scaffold for tissue regeneration. Because this biocomposite incorporates the advantageous properties of 
both collagen and carbon nanotubes, it has most of the characteristics that an ideal biomaterial requires in 
order to be used as an osteoinductive agent. This biocomposite is bioresorbable and biodegradable and has the 
desired mechanical rigidity while maintaining a three-dimensional(3-D) nanostructured surface. Tuned stability 
and swelling were achieved under fluid environments by varying the amount of carbon nanotubes (CNTs) 
incorporated into the composite. These variations can dictate the degree of interaction between fibroblastic 
cells and the biomaterials. Proof-of-concept was shown by performing an in vitro induced mineralization of 
hydroxylapatite crystals under physiological conditions. Furthermore, the ability to attach biofunctional groups 
to the CNT walls can open a new road for tissue regeneration since the combination of CNTs with specific 
growth factors or cellular ligands can create an environment capable of signaling and infl uencing specifi c cell 
functions. Our observations suggest that collagen/carbon nanotube biocomposites will have important uses in 
a wide range of biotechnological areas.
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Introduction
Bionanotechnology research involving biocomposite 
substrates has been rapidly developing in recent 
years and much work now focuses on a controllable 
integration between biological and artificial matter. 
One of the major goals in the field is to develop 
new biomimetic structures with a wide range 
of chemical and physical properties which will 
promote fabrication of a novel generation of medical 
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devices [1 6]. Especially notable is the application 
of nanotechnology in biomaterial development and 
tissue engineering. Such novel biomaterials have 
the potential to promote paradigm changes and to 
revolutionize the science and practice of medicine 
[1]. New advances in bone tissue engineering have 
motivated the search for new materials that are 
biocompatible with the different bioactive functions 
which actually occur in live, growing tissues [1, 2, 
7]. The next generation of biomaterials needs to be 
biodegradable and bioresorbable, characteristics 
which should allow new tissues to grow in their 
environment in a naturally controlled manner [1, 8, 
9]. These characteristics are of paramount importance 
because they will help to solve any long-term 
issues associated with integration of the implant 
with its surroundings and allow the biomaterial 
to be completely replaced by non-immunogenic, 
host-derived tissues.  The ideal scaffold also 
requires sufficient mechanical rigidity and a 
porous 3-D structure which can provide maximum 
integration with cells and body fluids, plus have a 
nanostructured surface which facilitates the adhesion 
of cells [1, 10, 11]. Additionally, the biomaterials 
should also be capable of modification so that it 
contains functional moieties (e.g., growth factors) 
that promote and stimulate the growth of new 
tissue. However, even in view of the many recent 
advancements in biotechnology, the development 
of a biomimetic scaffold with all of the above 
characteristics is still a challenge [5].
Since the 1960s, metals and alloys have been 
used to produce inert bone graft implants. In the 
1970s, ceramics and polymers (natural or synthetic) 
came into use as either bioactive or bioresorbable 
bone grafts. More recently, a third generation of 
biomaterials, such as composites and nanocomposites 
which have enhanced bioactive and bioresorbable 
properties, has emerged [1, 5, 8, 12]. Synthetic 
polymers have been widely used as a biodegradable 
material in tissue engineering [13, 14], whereas 
bio-derived materials, such as collagen, are being 
increasingly applied in regenerative medicine [5, 
15, 16]. The advantages of using a naturally-derived 
material arise from its biocompatibility and intrinsic 
biological recognition. For instance, bone can be 
considered to be a true nanocomposite since its matrix 
is mainly composed of inorganic (hydroxylapatite, 
HA) and organic phases (mainly collagen) [5, 9, 15]. 
The use of collagen as a biomaterial is an obvious 
choice since it is a biodegradable material, which 
can be resorbed by the body and cells can directly or 
indirectly adhere to it. However, its weak mechanical 
properties have hindered its use in a wide range of 
tissue engineering applications. As a consequence, 
much effort has focused on the development of 
collagen nanocomposites. In particular, collagen and 
HA nanocomposites have been intensively explored 
and shown promise as a bone regenerative scaffold 
[1, 5, 15, 17 19]. One can speculate that a major 
breakthrough in the use of nanotechnology in tissue 
engineering will occur when tailored nanomaterials 
with specific biofunctions are combined with 
naturally derived materials generating a novel 
scaffold with improved biological characteristics.
Carbon nanotubes (CNTs) are one nanomaterial 
that has a great potential for applications in bone 
regeneration  [4, 20 23]. Single and multi-walled 
carbon nanotubes (SWCNTs/MWCNTs) have 
diameters ranging from 0.7 nm to about 100 nm 
and lengths that can be thousands of times greater. 
These hollow, cylindrical carbon structures are 
among the strongest and stiffest materials known 
[24 26]. It is well established that the addition 
of small amounts of CNTs into polymers results 
in composites with improved mechanical and 
electrical properties [27 30]. Recently, advances 
in chemical functionalization of carbon nanotubes 
have made them much more attractive for use in 
biological applications [23, 31 34]. The ability to 
attach functional groups on the nanotube surface 
enables a wide range of possible applications such 
as biosensors, bio-delivery agents, and scaffolds for 
cellular growth, among others [35, 36]. Moreover, 
the ability of nanotubes to act as an osteoinductor 
has been recently demonstrated [37 39]. In these 
studies, functionalized CNTs were able to induce 
the nucleation and growth of HA crystals in vitro 
under physiological concentrations of Ca2+ and 
PO4
3 . Additionally, the interaction of CNTs with 
osteoblasts (bone-forming cells) has also been 
described and good biocompatibility and bone 
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formation have been observed [37 39]. Other 
work has also shown increased osteoblast alkaline 
phosphatase activity and calcium deposition when 
carbon fi bers and nanotubes were used as substrates 
for cell growth and increased osteoblast adhesion 
when a polyurethane/CNT composite was used as a 
substrate [20, 22].
Although much recent work has demonstrated 
that CNTs are a promising material for tissue 
engineering, nevertheless the lack of self-rigidity of 
CNTs hinders their application as an implantable 
biomaterial for bone regeneration. Therefore, in order 
to achieve the full potential of CNTs as scaffolds, it 
is crucial to combine them with a suitable matrix. 
Different biocompatible synthetic polymers such as 
polyvinyl alcohol (PVA), polymethyl methacrylate 
(PMMA), polycarbonate urethane (PU), and poly-
L-lactic acid (PLA) have been investigated as 
composites with CNTs [31 35]. Although these 
polymers lack mechanical strength, this can be 
mitigated by the addition of CNTs. In addition, 
CNTs can be more easily functionalized than such 
synthetic polymers. The use of natural polymers, 
however, seems to have a greater potential in 
tissue engineering. For example, collagen is one 
of the most common proteins in the connective 
tissues of vertebrates and plays crucial biological 
roles in structural maintenance, cell adhesion, cell 
migration, and tissue integrity and remodeling [40]. 
Collagens are produced by several cell types in the 
form of single, helical polypeptide chains (alpha 
chains), each about 1000 amino acids long, which 
self-associate into trimeric molecules and then into 
higher-order, durable fibrils and fibers. Thus, one 
can envision that the combination of the properties 
of collagen and CNTs could create a unique 
biomaterial with improved and novel characteristics. 
Nevertheless, investigation of the interactions of 
CNTs with collagen has been restricted to only 
a few studies [41 46]. CNTs functionalized with 
collagen molecules have been used to improve the 
mechanical properties of PVA/CNT composites 
[46]. MacDonald et al. showed that the presence of 
carboxylated CNTs in collagen/SWCNT composites 
did not alter the initial formation of gels containing 
live smooth muscle cells, nor affect the cell viability 
or proliferation of these cells. However, they noted 
that matrices containing 2 wt% SWCNTs showed a 
delay in gel compaction during the first three days 
of the experiment, indicating that CNTs improve the 
mechanical strength of the biocomposite gel [43]. In 
recent work, MacDonald et al. used collagen/CNT 
biocomposites to show that this product can be used 
as a substrate to study electrical stimulation of cells 
and can act as a transducer for future biosensors [44, 
45]. Cao et al. have described collagen/MWCNT 
composites which display better mechanical 
properties than pure collagen [41]. In this work, 
we describe a biocomposite that incorporates the 
advantageous properties of both collagen and carbon 
nanotubes. The collagen/nanotube composite 
developed here possessed most of the required 
characteristics that an ideal biomaterial needs in 
order to be used as an agent of osteoinduction for 
bone tissue regeneration. The biocomposite was 
bioresorbable and biodegradable and had the 
desired mechanical rigidity while maintaining a 3-D 
nanostructured surface. Tuned stability and swelling 
were also achieved in fl uid environments by varying 
the amount of CNTs incorporated into the composite. 
These variations can dictate the degree of interaction 
between fi broblastic cells and the biomaterial. Proof-
of-concept was shown by performing an in vitro 
induced mineralization of hydroxylapatite crystals 
under physiological conditions. It is clear that such 
biocomposites could have important applications in a 
wide range of biotechnological areas.
1. Experimental 
Carbon nanotube synthesis. SWCNTs were prepared 
by the arc discharge method using  Co and Ni as 
catalysts with helium atmosphere at total pressure 
500 Torr [47]. After synthesis, the material was 
purified by a sequence of thermal oxidation and 
acid treatments. The purified SWCNTs (1 g) were 
refl uxed in HNO3 (3 mol/L) in a domestic microwave 
oven for 15 min. After that, the material was 
centrifuged at 7000 rpm and washed with distilled 
water. The fi nal solution was dried for 12 h at 60 °C. 
The resulting material (~0.75 g of high purity) was 
then functionalized with COOH groups. A detailed 
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description of the functionalization methods as well 
as the characterization of the CNTs can be found in 
the Electronic Supplementary Material (ESM). 
Collagen extraction. Collagen type I was extracted 
from rat tails and cattle tendons. The tendons were 
separated, ground, and washed three times in 
phosphate buffer saline (PBS) and three times in 
ethanol (70%). Collagen was further extracted in 
acetic acid (0.5 mol/L) overnight and centrifuged 
(14,000 g, 1 h) to remove vessels and other insoluble 
particles.  The collagen was salt  precipitated 
(0.7 mol/L NaCl), resuspended with acetic acid 
(0.5 mol/L) and extensively dialyzed with acetic 
acid (0.02 mol/L). The fi nal concentration of the stock 
collagen solution, containing an estimated 97% 98% 
native type I collagen and 2%–3% type Ⅲ collagen, 
was 5.6 mg/mL.
Cells. 3T3 fibroblasts cells were maintained in 
25 cm2 tissue culture flasks in Dulbecco’s modified 
Eagle’s medium (DMEM) containing fetal bovine 
serum (FBS, 7%), penicillin G (100 units/mL), 
streptomycin (100 mg/mL) and amphotericin B 
(2.5 mg/mL). 3T3 fibroblasts were chosen for these 
studies since they can be induced to form bone and 
will be useful in future models of bone remodeling.
Biocomposite formation. An aqueous solution 
of collagen (5.6 mg/mL) was prepared in acetic 
acid with pH adjusted to between 2 and 4. This pH 
value had been previously optimized to enable a 
homogenous dispersion of SWCNTs in the collagen 
matrix. In parallel, a solution containing COOH-
SWCNTs (0.5 mg/mL, pH=5) was made using an 
ultrasonic bath. Varying amounts of the SWCNT 
solution were mixed into the collagen solution at a 
weight percent (milligrams SWCNT per milligrams 
collagen) of 0.2 wt%, 0.5 wt%, 1 wt%, 2 wt%, 3 wt%, 
or 4 wt%. Control constructs did not contain any 
COOH-SWCNTs (0 wt%). Finally, the pH of the 
solution was raised to pH 7.2 using NaOH. In neutral 
pH aqueous solution, collagen molecules reassociate 
into fi brils and form a gel. Solvents were removed by 
submitting the biocomposite gel to a lyophilization 
process. 
Transmittance measurements. Fourier transform 
infrared (FTIR) transmission spectra in the mid-
infrared region (650 4000 cm 1) were collected with 
a Centaurus microscope attached to a Nicolet-Nexus 
spectrometer. The samples were prepared by 
depositing several drops of the biocomposite 
solutions on undoped Si wafers. Reference spectra 
were taken in clean regions of the same wafers. The 
measurements were performed under nitrogen purge, 
with spectral resolution of 4 cm 1, by averaging 64 scans.
Stress and rupture tension measurements. The 
composites were subjected to load–deformation 
analysis using an Instron automated testing system. 
The experiments were carried out at a constant cross-
head speed of 5 mm/min with relative humidity 
of 60% at 25 32 °C. Before subjecting the samples 
to analysis, strip shaped samples of uniform width 
of 10 mm and thickness about 0.02 mm were dried 
in a desiccator. Statistical comparison of the results 
was determined by one-way ANOVA followed by 
Bonferroni’s test with the level of signifi cance set at 
P<0.05.
Swelling assay. The intumescent coatings were 
formulated using PBS buffer. A sample was immersed 
in PBS for an extended period of time and digital 
pictures taken on a daily basis. The pictures showed 
marked variation in the sample size and were used 
to probe the degree of swelling and integrity of the 
composites.
Gel contraction assay. Biocomposite gels were 
prepared as described above, but with inclusion of 
DMEM, FBS and antibiotics in the gel. The pH was 
adjusted to 7.2 with NaOH and COOH-SWCNTs 
were added in the following concentrations: 0, 0.625 
wt%, 1.25 wt% and 2.5 wt%. Cells were added at a 
concentration of 2.5 ×  105 cells/mL and then 1 mL of 
the mixture, in triplicate for each CNT concentration, 
was placed into wells on a 24-well plate. The plates 
were placed in an incubator at 37 °C, in 5 % CO2. 
After collagen gelation (1 h), 1 mL of culture medium 
was added to each well to maintain the cells during 
the experiment. In order to allow the cells to contract 
the gel, the gels were detached from the sides and 
bottom of the wells and the plates returned to 
the incubator and kept in culture for 7 days, with 
changes of medium every other day. Digital images 
of the gels within the wells were captured daily. The 
areas of the gels were determined using the Image 
J program (http://rsb.info.nih.gov/ij/, National 
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Institutes of Health, Bethesda, Maryland, USA). 
Statistical comparison of the results was determined 
by one-way ANOVA followed by Bonferroni’s test 
with the level of signifi cance set at P<0.05. 
Mineralization experiments.  A composite 
containing 4 wt% of COOH-SWCNTs was incubated 
in a vial containing 1 mmol/L CaCl2 (2 mL) and 0.5 
mmol/L Na2HPO4 (2 mL). A pure collagen sample 
was also incubated under the same conditions to 
be used as a reference. After mineralization for one 
and four weeks, the samples were taken out of the 
solution and rinsed carefully and thoroughly with 
water. The resulting dried samples were examined by 
scanning electron microscopy.
2. Results and discussion
Figures 1(a) and 1(c) show scanning electron 
micrographs of lyophilized collagen gels produced 
using collagen from bovine and rat, respectively. 
Structural changes were observed for composites 
prepared with 4 wt% of COOH-SWCNTs when 
compared with their pure collagen counterparts, see 
Fig. 1(b) (bovine) and Fig. 1(d) (rat), respectively. 
The presence of CNTs promoted a decrease in the 
porosity of the matrix and an enhanced nanostructure 
surface in the composites formed with both collagen 
sources, although some structural differences 
between collagen from rat and cattle were apparent. 
One of the main goals of developing a collagen/
CNT composite is to improve the poor mechanical 
properties of collagen, which have hindered a wider 
application of this molecule in bioengineering. To 
assess the degree of improvement, stress-strain 
curves were measured for both types of pure collagen 
and composites made with 4 wt% of COOH-SWCNTs 
(Fig. 2). The mechanical properties (tensile strength) 
of the composites were superior to those of the pure 
counterparts for both collagen sources. The pure 
collagen from rat showed a poor stress resistance 
and when CNTs were added to the matrix, the stress 
resistance increased by factor of about three. The pure 
collagen from bovine was more resistant to stress; 
the presence of CNTs also increased the resistance of 
the composite, but to a lower extent as compared to 
rat collagen. Rupture-tension experiments showed 
Figure 1 Scanning electron micrographs of pure collagen and 
collagen/carbon nanotube (CNT) composites: (a) bovine collagen; 
(b) bovine collagen composite; (c) rat collagen; (d) rat collagen 
composite. (a’), (b’), (c’), and (d’) show higher magnifi cation images 
of (a), (b), (c), and (d), respectively
that composites made with rat collagen were more 
resistant than composites made with bovine collagen. 
These differences may be attributed to the particular 
characteristics of each collagen. It is also important to 
note that the values of the tensile strength obtained 
were of the same order as those found in Ref. [48]. 
These results suggest that the collagen from rat tail 
tendon is more susceptible to improvement due to 
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(Fig. 3). The ratio of the absorbances of the bands at 
1235 and 1450 cm 1 can be used as a measurement 
of the integrity of the collagen triple helix structure. 
If a ratio of unity is found, collagen triple helices 
are present [49, 50]. Using this method we found an 
intensity ratio of about 0.9 for the collagen prepared 
by our method (both pure and composite). This 
confi rms that the procedure we applied to prepare the 
composite did not degrade the collagen molecules. 
All the peaks observed in the IR are consistent with 
vibrational modes of the proteins present in the 
collagen molecule.
Figure 2 Stress assay for composite (4 wt% CNTs) and pure 
collagen from bovine (a) and rat (b). Rupture-tension assays (c) 
showed that composite from rat collagen is more resistant than 
composite made with bovine collagen (P<0.05)
Figure 3 FTIR spectra of pure collagen (red) and composite with 
CNTs (4 wt%) (black)
Another aspect that is essential in a biomaterial 
is its stability under fl uid environments. One would 
expect that a material with tuned stability might have 
interesting applications in tissue engineering. One 
way to assess this property is to probe the degree 
of intumescence (or swelling) of the material. For 
instance, it is well known that when immersed in 
a fluid, collagen swells, absorbs and retains large 
amounts of water [51, 52]. Intumescence is a crucial 
property for tissue regeneration since the extent 
of this swelling, combined with the stability of the 
composite in this state will dictate the degree of 
interaction between the fl uid cells and the composite. 
If, for instance, one has a material with long-term 
stability and a high degree of swelling, an increased 
interaction between the cells and the biomaterial 
would be expected, consequently raising the chances 
of new tissue growth. Furthermore, ideally after 
sometime, the biomaterial would be degraded and 




CNT incorporation. Thus, we decided to continue the 
experiments using only the collagen isolated from 
this source. 
To demonstrate the integrity of collagen fi bers in 
the composite, infrared spectroscopy was performed 
Nano Research
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of two composites (0.2 wt% and 4 wt% COOH-
SWCNT) immersed in a physiological solution 
(PBS) for different immersion times (see Fig. S-1 in 
the ESM for the full set of pictures taken at different 
times). A picture of a pure collagen sample immersed 
in a physiological solution is not shown since the 
material degraded very easily and the solution 
became transparent. The effect of CNT addition on 
the composite stability can be indirectly probed by 
analyzing the general appearance and morphology 
of the immersed material over time. Analysis of 
Fig. 4 shows that noticeable changes can be already 
observed at day 15 for the composite with 0.2 wt% of 
CNTs. After this time, the composite started to lose its 
integrity and break apart. In contrast, the composite 
with 4 wt% of CNTs still maintained its expanded 
structure. The degradation process proceeded 
continuously for the composite with 0.2 wt% of CNTs 
until day 250, by which time the composite had lost 
most of its structure. Significantly less composite 
degradation was observed for the composite with the 
higher amount of CNTs (4 wt%).       
During the entire period of the study this 
composite was able to maintain its structure, and 
it only started to lose its form at day 250. These 
observations indicate that it is possible to control 
the degree of stability of the composite by altering 
the amount of CNTs incorporated. Thus, it would 
be possible to tune the composite for different 
applications in tissue engineering where shorter or 
longer times for tissue regeneration are required. This 
result also suggests that this biomaterial may be of 
great use not only for tissue engineering but also as a 
drug delivery agent [36].
Figure 4 Swelling assay. Composites were lyophilized and then placed in a tube with PBS. Pictures were taken over a 250 day period (the 
number of days is indicated above each fi gure). The composites disintegrated at different times, depending on the CNT concentration
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In  order  to  be  used as  scaffo ld  for  bone 
regeneration, it is important that a biocomposite 
maintains its original size and its 3-D structure when 
incorporated inside the body. When fibroblasts are 
embedded within a collagen gel, they are normally 
able to contract the gel, decreasing its volume. If the 
intended use of a biocomposite is to act as a scaffold, 
contraction should be avoided, since gaps would be 
formed between the tissue and the composite. The 
effect of CNTs on fibroblast cells within a collagen 
gel was investigated by performing a gel contraction 
assay. The primary goal of this experiment was to 
determine if the presence of CNTs alters the ability of 
the fibroblasts to contract the collagen gel and thus 
allows a structure that could be used as a scaffold 
to be maintained. The degree of gel contraction was 
assessed by measuring the sample areas (Fig. 5). We 
observed that the contraction of the biocomposite by 
3T3 cells was diminished in the presence of CNTs. 
At the end of experiment, the collagen gel without 
CNTs contracted by 22%, while the collagen gels with 
0.625 wt%, 1.25 wt%, and 2.5 wt% CNTs contracted 
by about 8%. Thus, the presence of CNTs inhibits 
the collagen gel contraction normally observed with 
3T3 cells, but no evidence of a CNT concentration 
dependence was found. The measured areas showed 
statistical signifi cance (P< 0.05) for almost all groups 
compared to the control at days 2 to 7 of analysis. The 
exception was the group with 0.625 wt% of CNTs at 
days 2 and 3. Our results are consistent with the idea 
that CNTs increase gel resistance, and thus the cells 
are not able to contract the gel. However, in order to 
validate this assumption, it will be necessary to run 
cell viability assays to determine whether CNTs are 
toxic or not, to exclude the possibility that killing of 
the cells was responsible for contraction of the gel.
Although several studies in the literatures have 
shown an association between CNTs and collagen, the 
degree of toxicity of CNTs has not been well defi ned 
[39, 53 55]. For instance, MacDonald et al. [43], using 
aortic smooth muscle cells, showed that constructs 
containing 2 wt% CNTs in a 2 mg/mL collagen gel 
exhibited delayed gel compaction compared to that 
observed with lower concentrations of CNTs and to 
the control (absence of CNTs). Importantly, they also 
determined that the cell viability was consistently 
Figure 5 In vitro collagen gel contraction by 3T3 fibroblast cells in the presence of different CNT concentrations (wt%). At the top, a 
representative gel contraction from day 1 to day 7. At the bottom, the graph shows the gel area measurements obtained with 3T3 cells. The 
areas were measured as units of squared pixels in the digital images
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above 85% in all the constructs. Although we 
did not test the viability of the cells to prove the 
biocompatibility of the composite, or test the 
migration of the cells within the gels [42], our results 
indicate that the composites might have an important 
biofunctionality, supporting our proposal that they 
can be used as a scaffold for bone regeneration and 
other applications in tissue engineering that require 
the biocomposite to retain its original structure.
Our fi nal experiment was to verify the potential of 
the collagen/CNT composite as an osteoinductor. We 
performed mineralization tests of the composite with 
HA (which is a naturally occurring form of calcium 
apatite and present as HA crystals in bone tissue) 
under physiological concentrations of Ca2+ and PO4
3 . 
These types of experiments have already successfully 
been done on pure CNTs, and demonstrated that 
CNTs are promising osteoinductors [37 39]. The 
idea behind these experiments was to assess if the 
nanocomposite within the body fluid would be 
able, in contact with small concentrations of Ca2+, to 
stimulate the formation of HA. Calcium salts in bone 
provide structural integrity to the skeleton, and they 
exist largely in the form of hydroxylapatite. 
The mineralization processes for pure 
col lagen and for  the  col lagen/CNT 
c o m p o s i t e  w e r e  p e r f o r m e d  u n d e r 
physiological concentrations of Ca2+ and 
PO4
3  ions: both materials were immersed 
in 0.5 mmol/L Na2HPO4 and 1 mmol/L 
CaCl2 solutions. In parallel, controlled 
deposi t ions  of  HA under  saturated 
(~millimolar range) and supersaturated 
(~molar range) concentrations of Ca2+ 
and PO4
3  ions were performed on clean 
silicon substrates (see Fig. S-2 in the 
ESM). As expected, no HA deposition was 
observed by exposing a silicon substrate 
to concentrations of Ca2+ and PO4
3  ions 
under physiological  concentrations. 
However, formation of HA crystals was 
clearly observed for supersaturated 
concentrations of Ca2+ and PO4
3  ions 
(Fig. S-2). Thus, this simple experiment 
demonstrated that it is necessary, under 
physiological concentrations of Ca2+ 
Figure 6 Scanning electron microscopy analysis of HA formation on collagen alone 
or on collagen composite after 1 and 4 weeks: (a) 1 week, collagen; (b) 4 weeks, 
collagen; (c) 1 week, collagen composite; (d) 4 weeks, collagen composite
and PO4
3  ions, to have nucleation centers present 
in order to induce the formation of HA crystals. 
Figure 6 depicts SEM micrographs for pure collagen 
and composite (4 wt% of CNTs) after exposure to 
physiological concentrations of Ca2+ and PO4
3  ions 
for 1 and 4 weeks. Interestingly, after exposure for 
1 week no evidence of HA crystals was found for 
the pure collagen material, while formation of some 
HA crystals was clearly observed on the collagen/
CNT composite. After exposure for 4 weeks, both 
materials were covered with HA crystals (verifi ed by 
IR spectroscopy not shown). However, it must be 
noted that different morphologies were found for the 
two materials. On the composite, in addition to the 
formation of HA crystals over the entire composite, 
we consistently found very large HA crystals (Fig. 
6(d)). These results indicate that not only does the 
nanostructure surface of both materials enable the 
formation of HA crystals, but also that, qualitatively, 
an increased induction of HA crystals was observed 
for the composite. This suggests that the increased 
mechanical rigidity combined with the enhanced 
nanostructured character of the composite are the 
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traits responsible for this improved performance. 
To date, very little is known about the interaction 
between these two species. Based on our results, it 
appears that CNTs can be incorporated into collagen 
fibrils during the initial interaction between the 
dispersed/solubilized collagen and CNTs in an 
aqueous medium. When collagen fibrillogenesis is 
initiated, CNTs may become incorporated into the 
triple-helical collagen molecule, or may remain as a 
separate phase linking the collagen fi bers. It is likely 
that the carboxyl and hydroxyl groups present on 
the surface of CNTs can form covalent and hydrogen 
bonds with amino groups extending from the 
collagen chains [41, 43]. However, further theoretical 
and experimental work still needs to be performed to 
clarify these assumptions. 
3. Conclusions 
A collagen/nanotube composite which has the 
potential to serve as a scaffold for tissue regeneration 
has been obtained. The biofunctionality (shape 
maintenance) associated with this biocomposite 
and the observation that the composite induces 
mineralization of HA crystals in vitro opens a wide 
range of new possibilities concerning its use for the 
tissue engineering of bone. In vivo tests are now 
necessary to further confi rm the biocompatibility and 
tissue regeneration characteristics of the composite. 
This scaffold may not only be biocompatible and 
biofunctional but also be bioactive and biodegradable. 
The nanostructure characteristics of the composite 
have the potential to promote osteoinduction which 
stimulates the growth of new bone tissue as well as 
providing a suitable interface between the native 
bone and the implant. In addition, the ability to 
attach biofunctional groups to the CNT walls will 
open a new avenue for tissue regeneration, since the 
combination of CNTs with specifi c growth factors or 
cellular ligands [1] can create a perfect environment 
to signal and infl uence specifi c or key cell functions. 
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